Literature DB >> 10336117

An immunohistochemical study of the distribution of brain-derived neurotrophic factor in the adult human brain, with particular reference to Alzheimer's disease.

M G Murer1, F Boissiere, Q Yan, S Hunot, J Villares, B Faucheux, Y Agid, E Hirsch, R Raisman-Vozari.   

Abstract

Brain-derived neurotrophic factor is a member of the family of neuronal differentiation and survival-promoting molecules called neurotrophins. Neuronal populations known to show responsiveness to the action of brain-derived neurotrophic factor include the cholinergic forebrain, mesencephalic dopaminergic, cortical, hippocampal and striatal neurons. This fact has aroused considerable interest in the possible contribution of an abnormal brain-derived neurotrophic factor function to the aetiology and physiopathology of different neurodegenerative disorders, such as Alzheimer's disease. This report describes the cellular and regional distribution of brain-derived neurotrophic factor in post mortem control human brain and in limited regions of the brain in patients with Alzheimer's disease, as was revealed by immunohistochemistry. Brain-derived neurotrophic factor is widely expressed in the control human brain, both by neurons and glia. In neurons, brain-derived neurotrophic factor was localized in the cell body, dendrites and axons. Among the structures showing the most intense immunohistochemical labeling were the hippocampus, claustrum, amygdala, bed nucleus of the stria terminalis, septum and the nucleus of the solitary tract. In the striatum, immunoreactivity was more intense in striosomes than in the matrix. Many labeled neurons were found in the substantia nigra pars compacta. The large putatively cholinergic neurons in the basal forebrain showed no immunoreactivity. The general pattern of labeling was similar in individuals with Alzheimer's disease. Brain-derived neurotrophic factor-immunoreactive material was found in senile plaques, and some immunoreactive cortical pyramidal neurons showed neurofibrillary tangles, suggesting that brain-derived neurotrophic factor may be involved in the process of neuronal degeneration and/or compensatory mechanisms which occur in this illness.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10336117     DOI: 10.1016/s0306-4522(98)00219-x

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  55 in total

1.  Minimal peroxide exposure of neuronal cells induces multifaceted adaptive responses.

Authors:  Wayne Chadwick; Yu Zhou; Sung-Soo Park; Liyun Wang; Nicholas Mitchell; Matthew D Stone; Kevin G Becker; Bronwen Martin; Stuart Maudsley
Journal:  PLoS One       Date:  2010-12-17       Impact factor: 3.240

2.  7,8-dihydroxyflavone prevents synaptic loss and memory deficits in a mouse model of Alzheimer's disease.

Authors:  Zhentao Zhang; Xia Liu; Jason P Schroeder; Chi-Bun Chan; Mingke Song; Shan Ping Yu; David Weinshenker; Keqiang Ye
Journal:  Neuropsychopharmacology       Date:  2013-09-11       Impact factor: 7.853

3.  A transgenic mouse model engineered to investigate human brain-derived neurotrophic factor in vivo.

Authors:  Fabrice Guillemot; Italina Cerutti; Charles Auffray; Marie-Dominique Devignes
Journal:  Transgenic Res       Date:  2007-01-16       Impact factor: 2.788

4.  Distribution of the hematopoietic growth factor G-CSF and its receptor in the adult human brain with specific reference to Alzheimer's disease.

Authors:  Sami Ridwan; Henrike Bauer; Katrin Frauenknecht; Kyra Hefti; Harald von Pein; Clemens J Sommer
Journal:  J Anat       Date:  2014-01-05       Impact factor: 2.610

5.  BDNF inhibits neurodegenerative disease-associated asparaginyl endopeptidase activity via phosphorylation by AKT.

Authors:  Zhi-Hao Wang; Wanqiang Wu; Seong Su Kang; Xia Liu; Zhiping Wu; Junmin Peng; Shan Ping Yu; Fredric P Manfredsson; Ivette M Sandoval; Xuebo Liu; Jian-Zhi Wang; Keqiang Ye
Journal:  JCI Insight       Date:  2018-08-23

6.  Tyrosine kinase B protein expression is reduced in the cerebellum of patients with bipolar disorder.

Authors:  Benchawanna Soontornniyomkij; Ian P Everall; Gursharan Chana; Ming T Tsuang; Cristian L Achim; Virawudh Soontornniyomkij
Journal:  J Affect Disord       Date:  2011-05-25       Impact factor: 4.839

7.  Hemodialysis decreases serum brain-derived neurotrophic factor concentration in humans.

Authors:  Jerzy A Zoladz; Michał Śmigielski; Joanna Majerczak; Łukasz R Nowak; Justyna Zapart-Bukowska; Olgierd Smoleński; Jan Kulpa; Krzysztof Duda; Joanna Drzewińska; Grzegorz Bartosz
Journal:  Neurochem Res       Date:  2012-08-19       Impact factor: 3.996

8.  Involvement of BDNF in age-dependent alterations in the hippocampus.

Authors:  Oliver von Bohlen und Halbach
Journal:  Front Aging Neurosci       Date:  2010-08-13       Impact factor: 5.750

9.  Brain-derived neurotrophic factor levels in late-life depression and comorbid mild cognitive impairment: a longitudinal study.

Authors:  Breno Satler Diniz; Charles F Reynolds; Amy Begley; Mary Amanda Dew; Stewart J Anderson; Francis Lotrich; Kirk I Erickson; Oscar Lopez; Howard Aizenstein; Etienne L Sibille; Meryl A Butters
Journal:  J Psychiatr Res       Date:  2013-11-20       Impact factor: 4.791

Review 10.  Brain-derived neurotrophic factor in neurodegenerative diseases.

Authors:  Chiara Zuccato; Elena Cattaneo
Journal:  Nat Rev Neurol       Date:  2009-06       Impact factor: 42.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.